BACKGROUND: All health care practitioners should be facile in the digital rectal exam (DRE) as it provides prostate, rectal and neurological information. The purpose of this study was first to justify our hypothesis that tissue elasticity is indicative of carcinomatous changes. Second, we employed urological surgeons to evaluate our prostate simulator in three ways: (1) authenticate that the elasticity of the simulated prostates accurately represents the range of normal prostate stiffness, (2) determine the range of nodule size reasonably palpable by DRE and (3) discern what degree of elasticity difference within the same prostate suggests malignancy.
Introduction
The digital rectal exam (DRE) is used by physicians to diagnose a variety of maladies, including prostate cancer. The very nature of insertion of the finger into the rectum means the physician, to make an informed diagnosis, must combine tactile cues with knowledge of the underlying anatomy and clinical history. Experienced physicians unconsciously synthesize tactile feedback on prostate tissue compliance and texture, size, shape, depth and firmness of abnormalities to detect disease. Firmer, non-tender tissue usually leads the physician to suspect carcinomatous pathology exists while fluctuance might suggest an abscess.
However, the DRE is inherently subjective, dependent on the experience of the examiner, and poorly reproducible. 1 Although PSA has been used as a serum tumor marker since the 1990s, sensitivity and specificity of PSA is poor. 2 The American Urological Association recommends a combination of DRE and PSA testing for prostate cancer screening. 3 When the microscopic and macroscopic structure of the tissue changes, as in pathological states, the mechanical properties of the tissue also change. For example, the contrast in elastic stiffness between normal and abnormal liver, breast and prostate tissue has been studied. 4, 5 Krouskop et al. [6] [7] [8] [9] characterized the elastic behavior of breast and prostatic tissue using an indentation technique under varying compression strains. Their results confirmed that malignant changes of the breast and prostate correlated with decreases in tissue elasticity.
However, the DRE is a difficult skill to teach due to its invasive nature and the fact that it cannot be combined with visual inspection. 10, 11 Several prostate simulators currently exist including the G300 life-size prostate model set (Anatomical Chart Company, Skokie, IL, USA) and the Life/form prostate examination simulator (Nasco, Fort Atkinson, WI, USA). However, these simulators present a very limited number of scenarios (3) (4) (5) (6) , either lack or misrepresent tactile cues, offer little feedback to learners and do not offer a range of 'normal' consistencies based on scientific measurement.
We felt it necessary to establish reliable measurements of prostate tissue properties in normal and diseased states to replicate 'clinical normal' for our Virginia Prostate Exam Simulator (VPES).
12 In a prior study we established: (1) a range of elastic modulus (EM) for postprostatectomy specimens, (2) the correlation of stiffness with pathological stage and (3) that within-prostate elasticity differentials exist. 13 This work confirmed that within a prostate, malignant tissue is consistently less elastic (more stiff) than healthy prostate tissue. However, although this ex vivo technique is robust scientifically, an in situ DRE has to contend with the anal sphincter, rectal wall and active blood flow.
To authenticate that our prostate simulator accurately reflects the tactile feedback experienced by practicing physicians in terms of range of prostate elasticity, lesion size and stiffness, we partnered with academic urologists. We first sought to justify our hypothesis that ex vivo prostate tissue elasticity is indicative of carcinomatous changes by correlating DRE findings with tissue elasticity and histopathology and second, to have urological surgeons evaluate our prostate simulator by: (1) authenticating that the elasticity of the simulated prostates accurately represents the range of normal prostate stiffness, (2) determine the range of nodule size reasonably palpable by DRE and (3) discern what degree of within-prostate elasticity difference suggests malignancy.
Materials and methods

Material characterization of radical prostatectomy specimens
We performed spherical indentation to characterize the material stiffness of 21 ex-vivo prostates within 20 min of surgical extirpation. We designed and built a spherical indentation rig to process whole-organ and crosssectioned ex vivo prostate gland tissue samples. The indenter tip is a 12 mm diameter steel ball mounted to an aluminum standoff, which is attached to a load cell with a 44 N maximum load capacity. The load cell is mounted to an aluminum sled, which is driven by a motorized linear stage with 100 mm travel and 50 mm s À1 maximum velocity. The cell is controlled by a motion controller, and a laptop computer is used for data acquisition and for operating the graphical user interface. 11 The indenter 'pushes' down on the intact prostate tissue and the force required to compress (that is displace) the tissue is calculated. After taking one measurement from each quadrant of the whole mount, prostate specimens were serially sectioned from apex to base into 0.5-1.0 cm slices. Spherical indenter measurements of the whole mount and cross-sections allowed calculation of load versus displacement data, which was used to compute EM. We performed standard tumor metastasis node pathological staging as well as pathological evaluation of the actual cross-section measured with the spherical indenter to determine within-prostate differentials. Full details of this methodology were previously published. 13 
Virginia prostate examination simulator
The VPES uses synthetic elastomers and expandable balloons to simulate the tactile cues of the prostate in both pathological and benign states. A multitude of disease scenarios can be presented to the subject by control of the balloons through the VPES test administrators computer interface. 14 The elasticity of the prostate models and lesion firmness was informed by prior material properties characterization and human-subjects experiments with medical students and residents.
Chart abstraction of clinical history
We performed chart abstraction to document the clinical indications for the prostatectomy, such as PSA level, body mass index, biopsy Gleason score and clinical stage as indicated by the DRE. We further delved into the physical exam as dictated by the urologist of record to assess for tactile cues, they may have assessed during DRE such as induration, asymmetry or extracapsular extension.
Human-subjects experiment with prostate simulator by urologists
In a 30-min, psychophysical experiment using the method of limits technique, 12 urological surgeons, naïve to the prostate simulator, qualitatively assessed prostate stiffness and nodule size.
14 To evaluate stiffness, the urologists palpated 10 prostates with incrementally greater (or lesser) EM values. The EM of these samples were 8.9, 12.9, 15.2, 20.7, 25.8, 34.3, 42.2, 51.9, 65.5 and 91 kPa. The method of limits technique is a scientific way to assess the relationship between stimulus and sensation. We employed an ascending and descending procedure to establish the thresholds of the prostate model, which when palpated was considered 'too soft' and 'too stiff' for normal prostate tissue by the urologists. We inquired about models whose elasticity progressively became less elastic, repeated the progression in reverse order and finally asked in a random order. Thereby, each participant's upper and lower limits of palpably normal prostate tissue can be calculated to establish a range for normal prostate stiffness.
A similar method was used for nodule size, where participants palpated balloons embedded in silicone ranging in size from 4 to 15 mm and gave their impression of nodule size (too small, within reasonable limits and too large) for those suspicious for prostate cancer. To determine the significance of within-organ stiffness differential between prostate and abnormality, urologists palpated six prostate scenarios, three each resembling benign prostate hypertrophy and carcinoma. There were two balloon sizes, 30 by 15 mm and 0.75 by 6 mm. The inflatable balloons created the effect of prostate nodules around 145.9 kPa for the 30 by 15 mm-sized balloon and 80.2 kPa for the 0.75 by 6 mm size. The stiffness of those balloons was measured outside of the silicone-elastomer matrix of the simulated prostate. All portions of the study were Institutional Review Board approved. Table 1 . Only 5% of the patients had a body mass index less than 25, and 33% (7/21) were obese. As seen in Table 1 , 66% (14/21) of patients were of clinical T1c stage and diagnosed by an abnormal PSA, and none had a Gleason score above 7. Table 2 correlates the findings on DRE and standard tumor metastasis node staging with the average tissue elasticity of the prostate. A total of 33% (7/21) had palpable asymmetry, firmness and/or a nodule on DRE. The final pathological stage revealed T3a disease in two patients (9.5%) although none had a Gleason score above 7.
Of the seven abnormal DREs, we wanted to specifically identify if the firmer areas palpated correlated with histological confirmation of adenocarcinoma. We found on the tissue cross sections that 85.7% (6/7) of the tactile cues that constituted a DRE abnormality correlated with location of pathology and histological evaluation. Table 3 depicts the DRE abnormality correlated with the standard TNM staging and our histological assessment by quadrant for the seven patients with an abnormal DRE. For patient 5, it is unknown if the DRE findings correlated with the location of pathology because carcinoma was not detected on this study's histological assessment by quadrant.
Authenticate that the elasticity of the simulated prostates accurately represents the range of normal prostate stiffness
In all, 12 urological surgeons at the University of Virginia (Table 4) , served as expert evaluators of the VPES (Figure 1 ). The 12 urologists had a total of 293 years of urology experience (average 24.4 years), and had by their estimate collectively performed over 14 000 career DREs. 
High-fidelity prostate exam simulator CG Kowalik et al
The VPES prostate models ranged in stiffness from 8.9-91 kPa (8.9, 12.9, 15.2, 20.7, 25.8, 34.3, 42.2, 51.9, 65.5 and 91). The urological surgeons determined the mean upper limit of stiffness palpated as realistic for a healthy prostate was 59.63 kPa (median 62.19 kPa) while the mean lower limit of stiffness was 27.1 kPa (median 27.33 kPa) as seen in Figure 2 .
Determine the range of nodule size reasonably palpable by DRE
In the assessment of nodule size, Figure 3 shows that nodule diameters less than 7.5 mm were felt to be too small to reasonably palpate. Of the 12 urological surgeons, 4 (33.3%) and 5 (41.6%) palpated the 5 mm and 4 mm nodules, respectively, and the majority agreeing that nodules less than 7.5 mm were too small to be palpated on DRE.
Discern what degree of within-prostate elasticity difference suggests malignancy
To evaluate within-prostate stiffness differential, the scenarios in Figure 4 were utilized. Each disease scenario had a simulated prostate of varying stiffnesses including 60.9, 34.1 and 19.2 kPa. Embedded in these simulated prostates were 15 mm or 7.5 mm balloons that measured 145.9 and 80.2 kPa. Thus the balloons were less elastic or stiffer than the background simulated prostate, and the participants were aware of the balloon positioning. A background prostate of 34.1 kPa with the 80.2 kPa nodules embedded in it was judged to be the most realistic by the urological surgeons. This translates to a stiffness differential of approximately 50 kPa. Nodule detection was least authentic and thus less detectable when embedded in the most-stiff prostate (60.9 kPa).
The purpose of this study was to authenticate, using materials characterization coupled with histopathology and human-subjects experiments with expert urologists, the tactile cues of the VPES, to maximize its clinical 
Discussion
In our prior study, mechanical testing results revealed that malignant tissue is less elastic than normal prostate tissue. Specifically, spherical indentation measurements identified a wide range of EM for normal (4.6-236.7 kPa) and malignant (7.0-978.3 kPa) prostate tissue with median EM values of 24.9 and 43.0 kPa, respectively. Tissue with histological benign prostate hypertrophy had increased EM values (median 27.3 kPa) compared with normal tissue. 13 In this study, we went a step further and linked the different EM values to clinical exam findings and identified the association of EM with physical exam findings and with histopathologic findings. Seven of our initial cohort of 21 patients had a suspicious cue on DRE. We found that based on tactile cues assessed by the urological surgeon, the firm area was indicative of a cancer in that area.
This body of work suggests one key underlying concept: it is not the absolute elasticity of the nodule, but rather the relationship of the nodule with the background prostate elasticity that constitutes the critical tactile feedback. This difference is what is palpated and processed by the urologist as 'abnormal', not the solitary finding of a 'hard spot.' The absolute EM of benign and malignant prostate tissue has a wide variance, suggesting that experience is needed to familiarize oneself with what is healthy tissue on DRE.
The underlying tenet for any DRE simulator is that a firmer area or 'nodule' is worrisome for malignancy. The concept of whether a measuring device, in this case DRE simulator, truly captures the theoretical concept is termed construct validity. We set out to prove construct validity for the VPES by 'proving' that firm areas on a prostate DRE are indeed more likely to be cancer. We did this by (1) quantifying the EM and then associating the elasticity with histological diagnosis of cancer and (2) associating DRE findings with both elasticy and stage of tumor. Both the quantitative and qualitative results showed that we can legitimately infer that a firm area is more likely to be cancer. Thus, the VPES prostate models do accurately reflect the pertinent DRE findings.
Our findings inform the range of prostate model EM considered normal by urologists fell within the range of normal prostate tissue EM from gross glands calculated by spherical indentation. The urologists did not have any information on the results of the spherical indenter study, so their findings are independent confirmation of the range of healthy prostate tissue. The wide range of malignant tissue EM makes establishing absolute values to delineate benign from malignant prostate tissue difficult; but the relationship of adenocarcinoma to normal tissue EM remained constant, with adenocarcinoma being less elastic. The urologists also provided feedback on the realism of the device (face validity). We will be able to use these findings to design valid and reliable prostate models. Likewise, we were able to determine what size nodule can 'realistically' be appreciated by a clinician which also informs our simu lator design. Urologists had more difficulty identifying nodules in prostates with decreased differences in elasticity between the prostate and the nodule. A within-tissue differential between prostate and nodule of approximately 50 kPa was most authentic. The urologic surgeons did not feel that nodules smaller than 7.5 mm could be High-fidelity prostate exam simulator CG Kowalik et al reliably discriminated from surrounding tissue on DRE. Therefore, scenarios involving these small lesions should be avoided in training programs. 15 Medical education curriculums employ standardized patients or physical simulators to teach the more intimate portions of the physical exam. The limitation of standardized patients is that most volunteers are 'normal.' Although simulators expose trainees to multiple disease scenarios, they may have an artificial tactile sensation and lack the perceptual cues of a real-life encounter. 16 A simulator that does not consider the learner's needs and the exam's sub-tasks and cues can be flawed, as seen with a virtual reality simulator (B$10 000) for teaching phlebotomy compared with a low-tech elastic model of the arm (B$100) 17 where the skills learned via the low-tech model transferred more accurately to subsequent interactions with patients.
The impetus behind the VPES is prostate cancer mortality. Prostate cancer continues to be the second leading cause of cancer-related deaths in American males. 18 We believe that DRE should be part of the education curriculum for all health care practitioners, and may become a more important weapon in our armamentarium if we move away from PSA screening. 19 Our results suggest that palpable abnormalities on DRE are diagnostic of adenocarcinoma. Histological studies confirmed that our simulated prostates accurately replicate the EM of both benign prostate tissue and carcinomatous changes. We further confirmed with independent urological surgeon qualitative studies that these EM models authentically replicate the tactile sensation of a clinical DRE. Finally, we ensured that our simulator provides accurate tactile cues in terms of within-prostate elasticity differences that are the backbone of clinical diagnosis.
Our study has several limitations. Ideally, the VPES would be tested by an additional number of urological surgeons. However, the expense is prohibitive while the VPES is in the prototype phase. The urological surgeons identified physiological inconsistencies in the current VPES, such as the simulated prostates being too close to the anal entrance. This resulted in the entire prostate being too accessible and being able to palpate the support apparatus. These modifications will be addressed in the next version. The EM values we identified with the spherical indenter are not the 'true' values found if one could measure EM in vivo given blood flow, oxygenation and so on. However, the methodology for measuring the EM of carcinoma versus benign was consistent throughout our study and thus we feel the relationship is valid. Additionally, expert opinion provided external confirmation that these values reflect what is palpated in practice.
Before being incorporated into medical education, we need to more rigorously test first another aspect of construct validity namely performance metrics. Performance metrics refer to the ability of the simulator to distinguish between novices, intermediates and experts. We further need to delve into transfer of training. Rarely do simulators actually scientifically measure whether the simulator actually improved clinical performance in a real world setting. Both of those are important future directions for us to undertake. Nonetheless, the VPES is the first simulator to monitor and capture finger motion and pressure to ensure teaching adequate coverage of the gland, present multiple (30 þ ) re-configurable scenarios of increasing difficulty and provide instantaneous feedback to the participant.
In conclusion, our study confirms a considerable overlap between tissue material property data and urologic surgeon opinion. Prostate simulator training may lead to greater familiarity with both the range of normal prostate elasticity and pertinent diagnostic cues. Our hope is that students will utilize the model to gain greater familiarity with the range of normal prostate elasticity and various prostatic disease processes. These tactile cues could then be transferred to a clinical setting to improve clinical accuracy of the DRE and the detection of early-stage, curable prostate cancer.
